Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06156228 · ClinicalTrials.gov registry record · NA
Multilevel Intervention of COVID-19 Vaccine Uptake Among Latinos
A NA study, sponsored by San Diego State University.
- Terminated
- Registry status
- NA
- Development phase
- 238
- Enrollment target
NCT06156228 is a NA study that was terminated before completion, run by San Diego State University. The registered enrollment target is 238 participants.
The verdict
NCT06156228, a NA study, was terminated before completion, sponsored by San Diego State University.
- TERMINATED
- Registry status
- NA
- Development phase
- 238 participants
- Enrollment target
Study Summary
This study is significant as it targets a population that has exceptionally high rates of morbidity and mortality due to COVID-19, influenza, pneumococcal pneumonia and shingles; and who demonstrate significant mistrust towards the vaccines. It is innovative in that investigators will harness the research team's extensive experience in developing multi-level and tailored interventions working with community partners to increase adult vaccine uptake among Latinos. Through this project the investigators will develop the experience and infrastructure for a scalable community-academic model that can be deployed and adapted to other communities (especially those with prevalent vaccine resistance) and other emerging public health threats. There is great potential for short- and long-term public health/economic impact in increasing adult vaccine uptake among high risk populations such as Latinos. This work will contribute to the body of evidence for effective behavioral- and community-based strategies to improve the health of Latinos.
Interventions
- BEHAVIORAL Multilevel Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 238 participants |
| Start Date | 2024-03-06 |
| Est. Completion | 2025-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06156228
The ClinicalTrials.gov registry entry for NCT06156228 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 238 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is San Diego State University, which has 118 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Multilevel Intervention is the first listed.
NCT06156228 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06156228 about?
NCT06156228 is a clinical study titled "Multilevel Intervention of COVID-19 Vaccine Uptake Among Latinos". This study is significant as it targets a population that has exceptionally high rates of morbidity and mortality due to COVID-19, influenza, pneumococcal pneumonia and shingles; and who demonstrate significant mistrust towards the vaccines. It is innovative in that investigators will harness the re...
What is the current status of trial NCT06156228?
This trial is currently terminated. It is a NA study. The enrollment target is 238 participants. The study started on 2024-03-06. Estimated completion is 2025-04-01.
What interventions are being tested in trial NCT06156228?
The interventions under investigation include: Multilevel Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT06156228?
This trial is sponsored by San Diego State University, which has 118 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.